Description
Tesamorelin is a synthetic growth hormone‑releasing hormone (GHRH) analogue that stimulates the pituitary gland to release endogenous growth hormone, increasing IGF‑1 levels. It is FDA‑approved for reducing excess abdominal fat in HIV‑associated lipodystrophy. By enhancing natural growth hormone pulses, it influences fat metabolism and body composition. In practical terms, tesamorelin is used clinically for specific fat‑redistribution conditions and studied for metabolic improvements.






Reviews
There are no reviews yet.